Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas
暂无分享,去创建一个
Jiyan Liu | Li-bo Liang | Ye Chen | Yuwen Zhou | K. Cheng | Yi-Xiu Long | K. Song | Yu-Wen Zhou
[1] G. Procopio,et al. Current Understanding of Urachal Adenocarcinoma and Management Strategy , 2020, Current Oncology Reports.
[2] L. Krane,et al. Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study. , 2019, Clinical genitourinary cancer.
[3] G. Procopio,et al. Urachal carcinoma: Towards a precision medicine , 2016 .
[4] Y. Lotan,et al. Effect of tumor location on survival in urinary bladder adenocarcinoma: A population-based analysis. , 2016, Urologic oncology.
[5] M. Amin,et al. Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin , 2016, Advances in anatomic pathology.
[6] B. Czerniak,et al. Urachal carcinoma: a pathologic and clinical study of 46 cases. , 2015, Human pathology.
[7] W. Choi,et al. Glandular Neoplasms of the Urachus: A Report of 55 Cases Emphasizing Mucinous Cystic Tumors With Proposed Classification , 2014, The American journal of surgical pathology.
[8] Jingbo Wu,et al. Options for diagnosis and treatment of urachal carcinoma , 2013, Asia-Pacific journal of clinical oncology.
[9] L. Kiemeney,et al. The clinical epidemiology of urachal carcinoma: results of a large, population based study. , 2012, The Journal of urology.
[10] A. Siefker-Radtke. Urachal adenocarcinoma: a clinician's guide for treatment. , 2012, Seminars in oncology.
[11] R. Dorin,et al. Pediatric Urology: Surgical Complications and Management , 2009 .
[12] E. Cheng. Pediatric Urology: Surgical Complications and Management, D.T. Wilcox, P.P. Godbole, M.A. Koyle. Wiley-Blackwell, Hoboken, New Jersey (2008), 386 pages , 2009 .
[13] V. Reuter,et al. Urachal Carcinoma: A Clinicopathologic Analysis of 24 Cases With Outcome Correlation , 2009, The American journal of surgical pathology.
[14] Yair Lotan,et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy , 2008, Cancer.
[15] Wun-Jae Kim. Multiple biomarkers improve prediction of bladder cancer progression and cancer specific survival , 2008 .
[16] V. Reuter,et al. Urachal carcinoma: contemporary surgical outcomes. , 2007, The Journal of urology.
[17] B. Leibovich,et al. Urachal carcinoma: Clinicopathologic features and long‐term outcomes of an aggressive malignancy , 2006, Cancer.
[18] P. Lange,et al. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder , 2006, Cancer.
[19] I. Sesterhenn,et al. World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .
[20] R. Millikan,et al. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. , 2003, The Journal of urology.
[21] P. Bassi,et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. , 1999, The Journal of urology.